UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals
Clinical trial NCT04714060 · UNKNOWN
Trial details
- NCT number
- NCT04714060
- Sponsor
- UBP Greater China (Shanghai) Co., Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-01
- Primary completion
- 2024-10-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.